Literature DB >> 21633771

Isolation of the first three cases of Clostridium difficile polymerase chain reaction ribotype 027 in Singapore.

P L Lim1, M L Ling, H Y Lee, T H Koh, A L Tan, E J Kuijper, S S Goh, B S Low, L P Ang, C Harmanus, R T Lin, P Krishnan, L James, C E Lee.   

Abstract

INTRODUCTION: The incidence of Clostridium (C.) difficile infection (CDI) was on the rise from 2001 to 2006 in Singapore. Recent unpublished data suggests that its incidence had remained stable or decreased in most local public hospitals between 2006 and 2010. It is, however, not known if the polymerase chain reaction (PCR) ribotype 027 strains have been circulating, although reports suggest that this strain is emerging in Asia, with the first cases reported from Japan in 2007, as well as in Hong Kong and Australia in 2009. We initiated a culture-based surveillance to detect this epidemic strain in Singapore.
METHODS: From September 2008 to December 2009, all non-duplicate toxin-positive stool samples from the three largest public hospitals in Singapore were collected for culture and further analysis.
RESULTS: Out of the 366 samples collected, 272 viable isolates were cultured. Of these, 240 tested toxin-positive and ten tested positive for the binary toxin gene; 35 different PCR ribotypes were found. Three isolates that tested positive for binary toxin contained the same PCR ribotyping pattern as the C. difficile 027 control strain. All three had the 18-bp deletion and single nucleotide tcdC deletion at position 117. Susceptibility testing was performed, demonstrating susceptibility to erythromycin and moxifloxacin.
CONCLUSION: We report the first three isolates of C. difficile 027 from Singapore. However, their susceptibility patterns are more consistent with the historical 027 strains. Rising CDI incidence may not be associated with the emergence of the epidemic 027 strain at this time.

Entities:  

Mesh:

Year:  2011        PMID: 21633771

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  12 in total

1.  Underestimation of Clostridium difficile infection among clinicians: an international survey.

Authors:  M N Mavros; V G Alexiou; K Z Vardakas; K Tsokali; T A Sardi; M E Falagas
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-03-27       Impact factor: 3.267

2.  Epidemiology of Clostridium (Clostridioides) difficile Infection in Southeast Asia.

Authors:  Peng An Khun; Thomas V Riley
Journal:  Am J Trop Med Hyg       Date:  2022-08-08       Impact factor: 3.707

Review 3.  Clostridium difficile Infection.

Authors:  Jae Hyun Shin; Esteban Chaves-Olarte; Cirle A Warren
Journal:  Microbiol Spectr       Date:  2016-06

4.  Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile.

Authors:  Kristin J Nagaro; S Tyler Phillips; Adam K Cheknis; Susan P Sambol; Walter E Zukowski; Stuart Johnson; Dale N Gerding
Journal:  Antimicrob Agents Chemother       Date:  2013-08-12       Impact factor: 5.191

5.  Using phenotype microarrays to determine culture conditions that induce or repress toxin production by Clostridium difficile and other microorganisms.

Authors:  Xiang-He Lei; Barry R Bochner
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

Review 6.  Clostridium difficile infection in the Lao People's Democratic Republic: first isolation and review of the literature.

Authors:  Elaine Cheong; Tamalee Roberts; Sayaphet Rattanavong; Thomas V Riley; Paul N Newton; David A B Dance
Journal:  BMC Infect Dis       Date:  2017-09-21       Impact factor: 3.090

7.  Comparative Genome Analysis and Global Phylogeny of the Toxin Variant Clostridium difficile PCR Ribotype 017 Reveals the Evolution of Two Independent Sublineages.

Authors:  M D Cairns; M D Preston; C L Hall; D N Gerding; P M Hawkey; H Kato; H Kim; E J Kuijper; T D Lawley; H Pituch; S Reid; B Kullin; T V Riley; K Solomon; P J Tsai; J S Weese; R A Stabler; B W Wren
Journal:  J Clin Microbiol       Date:  2016-12-28       Impact factor: 5.948

8.  Epidemiology of Clostridium difficile infection in Asia.

Authors:  Deirdre A Collins; Peter M Hawkey; Thomas V Riley
Journal:  Antimicrob Resist Infect Control       Date:  2013-07-01       Impact factor: 4.887

9.  Polymerase chain reaction ribotyping of Clostridium difficile isolates in Qatar: a hospital-based study.

Authors:  Asma A Al-Thani; Wedad S Hamdi; Naser A Al-Ansari; Sanjay H Doiphode; Godwin Justus Wilson
Journal:  BMC Infect Dis       Date:  2014-09-15       Impact factor: 3.090

10.  The First Two Clostridium difficile Ribotype 027/ST1 Isolates Identified in Beijing, China-an Emerging Problem or a Neglected Threat?

Authors:  Jing-Wei Cheng; Meng Xiao; Timothy Kudinha; Zhi-Peng Xu; Xin Hou; Lin-Ying Sun; Li Zhang; Xin Fan; Fanrong Kong; Ying-Chun Xu
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.